fluorodeoxyglucose f18 has been researched along with ribavirin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, M; Ishibashi, M; Kaida, H; Kurata, S; Matsuishi, T; Nagamitsu, S; Ohya, T; Shibuya, I; Yamashita, Y | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and ribavirin
Article | Year |
---|---|
A serial ¹⁸FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin.
Topics: Antiviral Agents; Cerebral Cortex; Child; Drug Therapy, Combination; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Interferon-alpha; Positron-Emission Tomography; Ribavirin; Subacute Sclerosing Panencephalitis | 2014 |